---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-022415"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2026-07-02T14:37:20+00:00"
generated_at: "2026-07-02T14:38:07.010093+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Integrated BioPharma extends revolving credit line to April 2027, enters $250K equipment note

## Summary
- Revolving line of credit extended to April 14, 2027; maximum principal remains $4,000,000.
- New $250,000 Convertible Line of Credit Note (Daily SOFR) for equipment/vehicles replaces matured $500,000 note.
- Interest on new note: Daily SOFR + 250 bps before conversion; after conversion, Daily SOFR or fixed rate at Bank's option.
- Amendment fee of $4,000 and legal fees of $2,500 paid to PNC Bank as conditions to effectiveness.
- Borrower reaffirms all security agreements, liens, and representations; no event of default exists.

## SEC filing metadata
- accession: 0001437749-26-022415
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2026-07-02T14:37:20+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774926022415/0001437749-26-022415-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774926022415/inbp20260630_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-022415
- JSON: https://secwatch.observer/filing/0001437749-26-022415.json
- Plain text: https://secwatch.observer/filing/0001437749-26-022415.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.